Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_assertion type Assertion NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_head.
- NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_assertion description "[To delineate if adipose tissue is the predominant organ responsible for anti-diabetic effects of FGF21, we treated mice with reduced body fat (lipodystrophy mice with adipose specific expression of active sterol regulatory element binding protein 1c; Tg) with recombinant murine FGF21 (rmuFGF21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_provenance.
- NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_assertion evidence source_evidence_literature NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_provenance.
- NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_assertion SIO_000772 22792234 NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_provenance.
- NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_assertion wasDerivedFrom befree-20150227 NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_provenance.
- NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_assertion wasGeneratedBy ECO_0000203 NP883000.RAZgm239KgDTkvhlMXKOyQY0aHIQnPqQqjdl6EiUVE9x0130_provenance.